FDA.reportPublic FDA data

mavacamten 15 MG Oral Capsule [Camzyos]

RxCUI
2600882
RxNorm name
mavacamten 15 MG Oral Capsule [Camzyos]
Display name
mavacamten 15 MG Oral Capsule [Camzyos]
Full name
mavacamten 15 MG Oral Capsule [Camzyos]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CAMZYOSMAVACAMTENMyokardia, Inc.669c936b-3ee6-4e36-8a22-79dd11b1255b2025-04-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2600882

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
669c936b-3ee6-4e36-8a22-79dd11b1255bCAMZYOS 15 MG Oral Capsule [PSN] · mavacamten 15 MG Oral Capsule [Camzyos] [SBD] · Camzyos 15 MG Oral Capsule [SY]38These highlights do not include all the information needed to use CAMZYOS safely and effectively. See full prescribing information for CAMZYOS. CAMZYOS ® (mavacamten) capsules for oral use Initial U.S. Approval: 202220250417